Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression

The Cancer Genome Atlas (TCGA) has classified papillary thyroid carcinoma (PTC) into indolent RAS-like and aggressive BRAF-like based on its distinct driver gene mutations. This retrospective study aimed to assess clinicopathology and pERK1/2 expression variations between BRAF-like and RAS-like PTCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Harahap, Agnes Stephanie, Subekti, Imam, Panigoro, Sonar Soni, Asmarinah, Lisnawati, Werdhani, Retno Asti, Agustina, Hasrayati, Khoirunnisa, Dina, Mutmainnah, Mutiah, Gultom, Fajar Lamhot, Assadyk, Abdillah Hasbi, Ham, Maria Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603905/
https://www.ncbi.nlm.nih.gov/pubmed/37893176
http://dx.doi.org/10.3390/biomedicines11102803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603905/
https://www.ncbi.nlm.nih.gov/pubmed/37893176
http://dx.doi.org/10.3390/biomedicines11102803

Ejemplares similares